6.00 USD
▲+0.23+4.53%
盘后 5.69 -0.87%
2026-08-03
市值
$1.18B
市盈率
—
EPS
-1.08
股息率
—
52 周区间
5.02 – 21.73
成交量
2.26M
Beta
-1.29
目标价
19.38
52W 低 5.0252W 高 21.73
价格走势
公司简介
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company’s medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; WVE-007, a GalNAc...